Dimethylenastron is primarily investigated for its potential applications in cancer research. It functions as a kinesin spindle protein inhibitor, which plays a critical role in cell division. By disrupting the activity of this protein, it can prevent the proliferation of cancer cells, making it a promising candidate for the development of anti-cancer therapies. Research is focused on its efficacy in targeting various types of tumors, particularly in preclinical studies. Additionally, its mechanism of action is being explored to understand its potential in combination with other chemotherapeutic agents to enhance treatment outcomes.